Searchable abstracts of presentations at key conferences in endocrinology

ea0025p263 | Reproduction | SFEBES2011

Endocrine disruptors and their association with male reproductive disorders and testicular dysgenesis syndrome: establishing a xenografting model of human fetal testis development

Mitchell Rod , Saunders Philippa , Childs Andrew , Cassidy-Kojima Claire , Anderson Richard , Wallace Hamish , Kelnar Chris , Sharpe Richard

Testicular dysgenesis syndrome (TDS) is a group of associated conditions (testicular germ cell tumours (TGCT), cryptorchidism, hypospadias and low sperm counts) that are thought to have a common origin in fetal life. Exposure of fetal rats to environmental chemicals such as the endocrine disrupting chemical di(n-butyl) phthalate (DBP) results in a TDS-like syndrome. However, exposed rats do not develop TGCT and the rodent is a poor model in this context. The effects of ...

ea0015oc34 | Thyroid | SFEBES2008

Maternal isodisomy for a novel human FOXE1 gene mutation in syndromic congenital hypothyroidsim

Castanet Mireille , Mallya Uma , Agostini Maura , Mitchell Catherine , Polak Michel , Demuth Stephanie , Raymond Lucy , Gurnell Mark , Chatterjee Krishna

Congenital hypothyroidism (CH), occurs with a frequency of one in 3–4000 and is most commonly due (85%) to complete or partial failure of thyroid gland development (dysgenesis). Several transcription factors (TTF-1/Nkx2.1, TTF-2/FOXE1, PAX-8), are highly expressed in the developing rodent thyroid. We first showed that the FKHL15 gene is the human homologue of TTF-2, identifying a homozygous, loss-of-function, mutation in two siblings with CH, thyroid agenesis, clef...

ea0050p273 | Neuroendocrinology and Pituitary | SFEBES2017

Cyclooxygenase-2 is a potential target for the treatment of Adamantinomatous craniopharyngioma

Scagliotti Valeria , Gutierrez Lorena Perez , Gualtieri Angelica , Jimenez Fernando , Kirkby Nicholas , Mitchell Jane , Warner Timothy , Gevers Evelien , Dattani Mehul , Gaston-Massuet Carles

Adamantinomatous craniopharyngiomas (ACPs) are among the most common intracranial tumours in children and they originate from undifferentiated pituitary progenitors. Mutations in the gene encoding for β-catenin (CTNNB1), which lead to the constitutive activation of the Wnt/β-catenin signalling pathway, have been associated with ACP. These tumours can invade adjacent structures, such as the hypothalamus, which makes comp...

ea0050p320 | Obesity and Metabolism | SFEBES2017

Androgen excess is highly prevalent in women with idiopathic intracranial hypertension and is biochemically distinct from polycystic ovary syndromes

O'Reilly Michael , Hornby Catherine , Westgate Connar , Botfield Hannah , Markey Keira , Mitchell James , Jenkinson Carl , Gilligan Lorna , Sherlock Mark , Gibney James , Tomlinson Jeremy , Arlt Wiebke , Sinclair Alexandra

Idiopathic intracranial hypertension (IIH) is a condition of unknown aetiology characterised by raised intracranial pressure, chronic headaches and blindness. Akin to polycystic ovary syndrome (PCOS), IIH patients are almost exclusively obese females of reproductive age. A distinct androgen excess profile has been noted in PCOS. Here, we aimed to delineate androgen metabolism in IIH compared to PCOS and simple obesity.Women w...

ea0050p273 | Neuroendocrinology and Pituitary | SFEBES2017

Cyclooxygenase-2 is a potential target for the treatment of Adamantinomatous craniopharyngioma

Scagliotti Valeria , Gutierrez Lorena Perez , Gualtieri Angelica , Jimenez Fernando , Kirkby Nicholas , Mitchell Jane , Warner Timothy , Gevers Evelien , Dattani Mehul , Gaston-Massuet Carles

Adamantinomatous craniopharyngiomas (ACPs) are among the most common intracranial tumours in children and they originate from undifferentiated pituitary progenitors. Mutations in the gene encoding for β-catenin (CTNNB1), which lead to the constitutive activation of the Wnt/β-catenin signalling pathway, have been associated with ACP. These tumours can invade adjacent structures, such as the hypothalamus, which makes comp...

ea0050p320 | Obesity and Metabolism | SFEBES2017

Androgen excess is highly prevalent in women with idiopathic intracranial hypertension and is biochemically distinct from polycystic ovary syndromes

O'Reilly Michael , Hornby Catherine , Westgate Connar , Botfield Hannah , Markey Keira , Mitchell James , Jenkinson Carl , Gilligan Lorna , Sherlock Mark , Gibney James , Tomlinson Jeremy , Arlt Wiebke , Sinclair Alexandra

Idiopathic intracranial hypertension (IIH) is a condition of unknown aetiology characterised by raised intracranial pressure, chronic headaches and blindness. Akin to polycystic ovary syndrome (PCOS), IIH patients are almost exclusively obese females of reproductive age. A distinct androgen excess profile has been noted in PCOS. Here, we aimed to delineate androgen metabolism in IIH compared to PCOS and simple obesity.Women w...

ea0065p181 | Metabolism and Obesity | SFEBES2019

The progesterone metabolite epiallopregnanolone sulphate induces glucose-stimulated insulin secretion from human and mouse islets and is reduced in gestational diabetes mellitus

Fan Hei Man , Bellafante Elena , Mitchell Alice , Ovadia Caroline , Martineau Marcus , Jones Peter , McCance David , Marschall Hanns-Ulrich , Hunt Kate , Bewick Gavin , Bowe James , Williamson Catherine

Serum concentrations of progesterone sulphates are raised in intrahepatic cholestasis of pregnancy (ICP), the commonest pregnancy-specific liver disease. Women with ICP have increased rates of gestational diabetes mellitus (GDM). We hypothesised that raised progesterone sulphates may modulate glucose homeostasis. Progesterone sulphates were assayed in serum samples from participants of the hyperglycaemia and adverse pregnancy outcomes (HAPO) study (n=79–94), and ...

ea0065p290 | Neuroendocrinology | SFEBES2019

The prevalence of acromegaly in the sleep apnoea clinic

Lynch Julie , Kyriakakis Nikolaos , Elliott Mark , Baldwin Lisa , James Anneli , Seejore Khyatisha , Ghosh Dipansu , Nix Mitchell , Watts Sue , Sathyapalan Thozhukat , Murray Robert D

Introduction: The prevalence of acromegaly in the general population ranges 4−14/100 000. 45−80% of acromegaly patients have obstructive sleep apnoea (OSA). The OSA population might represent a target group for earlier detection of acromegaly, thereby reducing associated long-term morbidity.Methods: Patients attending the sleep service (11/2014−04/2018) were recruited in a prospective multicentre cohort study. All had serum IGF-1 measur...

ea0063p955 | Diabetes, Obesity and Metabolism 3 | ECE2019

Transgenic production of endogenous n-3 PUFA levels compared to fish oil intake differentially improve obesity-related metabolic disorders: role of the gut microbiota

Barz Melanie Le , Daniel Noemie , Varin Thibault V , Mitchell Patricia , Pilon Genevieve , Gauthier Josee , Garofalo Carole , Kang Jing X , Roy Denis , Jobin Christian , Levy Emile , Marette Andre

Previous studies demonstrated that n-3 polyunsaturated fatty acids (PUFA) reduce insulin resistance and non-alcoholic fatty liver disease (NAFLD). However, we previously reported that transgenic expression of the fat-1 n-3 desaturase, inducing the endogenous production of n-3 PUFA, improved insulin resistance but not hepatic steatosis in a mouse model of obesity. Thus, we compared the effects of increasing n-3 PUFA levels through oral or endogenous approaches in diet-...

ea0049ep802 | Nuclear receptors and Signal transduction | ECE2017

5α-THB as a novel anti-inflammatory drug: The roles of the glucocorticoid and mineralocorticoid receptors

Abernethie Amber , Gastaldello A , Morgan RA , Mitchell C , McInnes KJ , Beck K , Odermatt A , Houtman R , Melchars D , Meijer OC , Hadoke PWF , Livingstone DEW , Walker BR , Andrew R

Glucocorticoids (GC) are potent anti-inflammatory compounds, acting mainly through the glucocorticoid receptor (GR). GC therapy, however, has debilitating side-effects, necessitating safer new alternative therapies. The natural GC metabolite 5α-Tetrahydrocorticosterone (5αTHB) is anti-inflammatory in vivo in mice, but with fewer side-effects. Its mechanism of action is unknown, and here we test signalling via GR and the mineralocorticoid receptor (MR). 5&#94...